World AIDS Day 2016 Virtual Special Issue Article Collection

The era of the Sustainable Development Goals has begun, and while HIV is no longer in the headlines of the global development agenda, ongoing commitment to the fight against HIV/AIDS will be crucial to various aspects of the new development targets. Revised international guidance on treatment—recommending immediate treatment for all patients with HIV—recognises the importance of treatment for all, but presents challenges: identification of people with undiagnosed HIV, particularly those with acute infection who are responsible for many transmissions; initiation of treatment soon after diagnosis; provision of affordable care in resource-limited settings; and retention of people in care. The Global Burden of Disease Study and UNAIDS figures both show an incidence greater than 2 million cases a year that remains little changed in the past decade, indicating that current approaches to prevention are not working. In 2016, these figures gave pause to the optimism of recent years and a reassessment of how to make the most of preventive approaches to address the critical issue of HIV incidence globally, nationally, locally, and in key populations. The targets call for an end to AIDS by 2030; opportunities exist to rapidly head toward that goal, but commitment to the fight against HIV/AIDS is under threat at every level. Researchers must work to show the continued value of beating HIV/AIDS and continue to innovate in prevention, treatment, and delivery to optimise the outcomes of from investments.

Peter Hayward
Editor, The Lancet HIV


We are pleased to present this virtual special issue of HIV/AIDS-related articles for World AIDS Day, selected from the following journals:

Clinical Microbiology and Infection
Human Microbiome Journal
IDCases
International Journal of Infectious Diseases
Journal of Clinical Virology
Journal of Infection
The Lancet HIV
The Lancet Infectious Diseases
Travel Medicine And Infectious Diseases


Clinical Microbiology and Infection

A single untimed plasma drug concentration measurement during low-level HIV viremia predicts virologic failure
Clinical Microbiology and Infection, In Press, Corrected Proof, Available online 30 August 2016A.
Gonzalez-Serna, L.C. Swenson, B. Watson, W. Zhang, A. Nohpal, K. Auyeung, J.S. Montaner, P.R. Harrigan

Pros and cons of circumcision: an evidence-based overview
Clinical Microbiology and Infection, Volume 22, Issue 9, September 2016, Pages 768-774
B. Friedman, J. Khoury, N. Petersiel, T. Yahalomi, M. Paul, A. Neuberger

Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: data from the ICONA cohort.
Clinical Microbiology and Infection, Volume 22, Issue 3, March 2016, Pages 288.e1-288.e8
A. Saracino, P. Lorenzini, S. Lo Caputo, E. Girardi, F. Castelli, P. Bonfanti, S. Rusconi, P. Caramello, N. Abrescia, C. Mussini, L. Monno, A. d’Arminio Monforte, ICONA Foundation Study Group


Human Microbiome Journal

Impact of HIV on the human gut microbiota: Challenges and perspectives
Human Microbiome Journal, Volume 2, December 2016, Pages 3-9
Grégory Dubourg


IDCases

HTLV-1 and HIV-1 co-infection: A case report and review of the literature
IDCases, Volume 4, 2016, Pages 53-55
Carmen Isache, Michael Sands, Nilmarie Guzman, Danisha Figueroa

Necrotizing retinitis due to syphilis in a patient with AIDS
IDCases, Volume 6, 2016, Pages 17-19
Takashi Shinha, Bree A. Weaver

Splenic tuberculosis in a patient with newly diagnosed advanced HIV infection
IDCases, Volume 6, 2016, Pages 20-22
B. Tiri, L.M. Saraca, E. Luciano, F.R. Burkert, S. Cappanera, E. Cenci, D. Francisci


Journal of Clinical Virology

Detection and quantification of HIV-1 RNA with a fully automated transcription-mediated-amplification assay
Journal of Clinical Virology, Volume 84, November 2016, Pages 70-73
K. Sauné, S. Raymond, J. Boineau, C. Pasquier, J. Izopet

Impact of circulating resistance-associated mutations on HIV pre-exposure prophylaxis (PrEP) efficacy: Modeling from antiretroviral resistance cohort analysis (ARCA) national database
Journal of Clinical Virology, Volume 83, October 2016, Pages 48-53
Roberto Rossotti, Vanni Borghi, Anna Paola Callegaro, Valeria Micheli, Bianca Bruzzone, Grazia Colao, Maria Rita Gismondo, Ilaria Vicenti, Giovanni Penco, Maurizio Zazzi, Stefano Rusconi


Journal of Infection

IP-10 differentiates between active and latent tuberculosis irrespective of HIV status and declines during therapy
Journal of Infection, Volume 70, Issue 4, April 2015, Pages 381-391
I. Wergeland, N. Pullar, J. Assmus, T. Ueland, K. Tonby, S. Feruglio, D. Kvale, J.K. Damås, P. Aukrust, T.E. Mollnes, A.M. Dyrhol-Riise

Alpha, beta and gamma Human Papillomaviruses in the anal canal of HIV-infected and uninfected men who have sex with men
Journal of Infection, Volume 71, Issue 1, July 2015, Pages 74-84
Maria Gabriella Donà, Tarik Gheit, Alessandra Latini, Maria Benevolo, Montserrat Torres, Vitaly Smelov, Sandrine McKay-Chopin, Amalia Giglio, Antonio Cristaudo, Mauro Zaccarelli, Massimo Tommasino, Massimo Giuliani

High hepatitis E virus seroprevalence with absence of chronic infection in HIV-infected patients
Journal of Infection, Volume 70, Issue 6, June 2015, Pages 624-630
Antonio Rivero-Juarez, Loreto Martinez-Dueñas, Antonio Martinez-Peinado, Angela Camacho, Celia Cifuentes, Ana Gordon, Mario Frias, Julian Torre-Cisneros, Juan A. Pineda, Antonio Rivero


International Journal of Infectious Diseases

HIV/AIDS: trends in the Middle East and North Africa region
International Journal of Infectious Diseases, Volume 44, March 2016, Pages 66-73
Deniz Gökengin, Fardad Doroudi, Johnny Tohme, Ben Collins, Navid Madani


The Lancet HIV

Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2015: the Global Burden of Disease Study 2015
The Lancet HIV, Volume 3, Issue 8, August 2016, Pages e361-e387
GBD 2015 HIV Collaborators

Weekends-off efavirenz-based antiretroviral therapy in HIV-infected children, adolescents, and young adults (BREATHER): a randomised, open-label, non-inferiority, phase 2/3 trial
The Lancet HIV, Volume 3, Issue 9, September 2016, Pages e421-e430
The BREATHER (PENTA 16) Trial Group

Cognitive behavioural therapy for adherence and depression in patients with HIV: a three-arm randomised controlled trial
The Lancet HIV, Volume 3, Issue 11, November 2016, Pages e529-e538
Steven A Safren, C Andres Bedoya, Conall O'Cleirigh, Katie B Biello, Megan M Pinkston, Michael D Stein, Lara Traeger, Erna Kojic, Gregory K Robbins, Jonathan A Lerner, Debra S Herman, Matthew J Mimiaga, Kenneth H Mayer


The Lancet Infectious Diseases

Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study
The Lancet Infectious Diseases, Volume 16, Issue 5, May 2016, Pages 565-575
The TenoRes Study Group

Testing the hypothesis that treatment can eliminate HIV: a nationwide, population-based study of the Danish HIV epidemic in men who have sex with men
The Lancet Infectious Diseases, Volume 16, Issue 7, July 2016, Pages 789-796
Justin T Okano, Danielle Robbins, Laurence Palk, Jan Gerstoft, Niels Obel, Sally Blower

Cost-effectiveness analysis of pre-exposure prophylaxis for HIV-1 prevention in the Netherlands: a mathematical modelling study
The Lancet Infectious Diseases, In Press, Corrected Proof, Available online 22 September 2016
Brooke E Nichols, Charles A B Boucher, Marc van der Valk, Bart J A Rijnders, David A M C van de Vijver

The Lancet Infectious Diseases HIV Prevention Resource Center, sponsored by the Centers for Disease Control and Prevention, provides valuable resources, a CME-certified program, plus scientific articles for clinicians to learn evidenced-based approaches to routinely incorporate HIV-prevention discussions into their practice. Free materials are available for providers to use with their patients, to promote appropriate HIV prevention strategies.


Travel Medicine And Infectious Diseases

Emergence of co-infection of visceral leishmaniasis in HIV-positive patients in northeast Iran: A preliminary study
Travel Medicine and Infectious Disease, Volume 12, Issue 2, March–April 2014, Pages 173-178
Reza Shafiei, Mehdi Mohebali, Behnaz Akhoundi, Meysam Sharifdini Galian, Fathollah Kalantar, Saeedeh Ashkan, Abdolmajid Fata, Bibi Razieh Hosseini Farash, Mehrdad Ghasemian

Travelling with HIV: A cross sectional analysis of Danish HIV-infected patients
Travel Medicine and Infectious Disease, Volume 12, Issue 1, January–February 2014, Pages 72-78
Ulla S. Nielsen, Søren Jensen-Fangel, Gitte Pedersen, Nicolai Lohse, Court Pedersen, Gitte Kronborg, Niels Obel, Carsten S. Larsen

Trends and characteristics among HIV-infected and diabetic travelers seeking pre-travel advice
Travel Medicine and Infectious Disease, Volume 12, Issue 1, January–February 2014, Pages 79–83
Floor Elfrink, Anneke van den Hoek, Gerard J.B. Sonder

A repeated syphilis infection imported from Thailand in an HIV positive couple of men-who-have-sex-with-men in Czech Republic
Travel Medicine and Infectious Disease, Volume 12, Issue 1, January–February 2014, Pages 84–87
Miloslav Salavec, Vanda Bostik, Jaroslav Kapla, Stanislav Plisek, Petr Prasil, Roman Prymula, Pavel Bostik